Categories: Health

Financire de Tubize – 2025 half-year financial report

 | Source: Financière de Tubize SA

Half-year financial report 2025
Regulated information 2 August 2025

The board of directors of Financière de Tubize has established the 2025 half-year report. This report is available on the website www.financiere-tubize.be.

  • Profit for the first half of 2025: € 95.6 million (€ 92.9 million in 2024, + 2.8%),
  • Dividend received from UCB: € 98.1 million (€ 1.39 per share, an increase of 2.2% compared to the previous year),
  • 2024 Dividend paid to Financière de Tubize’s shareholders in 2025 of € 46.3 million (€ 1.04 per share, an increase of 7.22% compared to the previous year),
  • Acquisition, in 2025, of 24,487 UCB shares, for a total amount of € 4.37 million, at an average price of € 178.3. Our stake in UCB has increased from 36.27% on 31 December 2024 to 36,28% on 30 June 2025,
  • Decrease of outstanding bank borrowings from € 41.3 million at 31 December 2024 to € nil at 30 June 2025.
GlobeNews Wire

Recent Posts

Bybit Lists StraitsX USD (XUSD) and Launches XUSD HODLverse With 60,000 XUSD in Rewards

DUBAI, UAE, Sept. 11, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume,…

2 hours ago

Elliott Statement on The Kansai Electric Power Company, Inc.

LONDON, Sept. 10, 2025 /PRNewswire/ -- Elliott Investment Management L.P. and Elliott Advisors (UK) Limited…

2 hours ago

GAC Shines at IAA MOBILITY Munich with AION V Officially Entering Europe, Accelerating the “European Market Plan”

MUNICH, Sept. 8, 2025 /PRNewswire/ -- On September 8, 2025, IAA MOBILITY 2025 officially opened in…

6 hours ago

Rising Star ASTRAUX Shines at IFA Berlin, Accelerates Expansion Across Key EU Markets

BERLIN, Sept. 8, 2025 /PRNewswire/ -- Dubai-based lifestyle tech brand ASTRAUX made a powerful statement…

6 hours ago

Avicanna Announces Change in CFO

September 12, 2025 18:00 ET  | Source: Avicanna Inc. TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE)…

8 hours ago

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 12, 2025 16:30 ET  | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass., Sept. 12, 2025…

8 hours ago